|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/70 | |
| A61K 31/4468 | |||
| A61P 17/00 | |||
| A61K 47/10 | |||
| A61K 47/16 | |||
| A61K 47/22 | |||
| A61K 31/4535 | |||
| A61K 47/14 |
| (11) | Patento numeris | 2759294 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12833553.6 |
| Europos patento paraiškos padavimo data | 2012-09-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-07-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2012/007599 |
| Data | 2012-09-21 |
| (87) | Numeris | WO 2013/042989 |
| Data | 2013-03-28 |
| (30) | Numeris | Data | Šalis |
| 20110095787 | 2011-09-22 | KR |
| (72) |
YU, Hyun-Suk, KR
LEE, Young-Moo, KR
KIM, Hyun-Woo, KR
KIM, Hee-Sook, KR
|
| (73) |
Samyang Biopharmaceuticals Corporation,
263, Yeonji-dong Jongno-gu, Seoul 110-725,
KR
|
| (54) | Formulation for percutaneous administration containing Fentanyl and analague thereof |
| Formulation for percutaneous administration containing Fentanyl and analague thereof |